Breaking News Instant updates and real-time market news.

CTSH

Cognizant

$71.42

0.49 (0.69%)

, MX

MagnaChip

$11.45

-0.35 (-2.97%)

04:55
09/08/17
09/08
04:55
09/08/17
04:55

Citigroup to hold a conference

2017 Global Technology Conference is being held in New York on September 6-8.

CTSH

Cognizant

$71.42

0.49 (0.69%)

MX

MagnaChip

$11.45

-0.35 (-2.97%)

SLAB

Silicon Laboratories

$74.65

-1.3 (-1.71%)

XRX

Xerox

$31.88

-0.27 (-0.84%)

WIX

Wix.com

$66.15

1 (1.53%)

QRVO

Qorvo

$73.22

-0.1 (-0.14%)

TRVG

trivago

$11.51

-0.98 (-7.85%)

MKSI

MKS Instruments

$84.90

1.65 (1.98%)

TEL

TE Connectivity

$78.80

-0.35 (-0.44%)

TXN

Texas Instruments

$82.00

-0.07 (-0.09%)

FEYE

FireEye

$15.77

0.99 (6.70%)

MXIM

Maxim Integrated

$46.36

-0.2 (-0.43%)

TYL

Tyler Technologies

$169.87

-0.23 (-0.14%)

AMKR

Amkor Technology

$8.90

-0.03 (-0.34%)

PFPT

Proofpoint

$91.66

0.92 (1.01%)

GWRE

Guidewire

$80.06

6.83 (9.33%)

BL

BlackLine

$32.18

1.31 (4.24%)

IIVI

II-VI

$36.50

0.05 (0.14%)

BRKS

Brooks Automation

$27.23

1.44 (5.58%)

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 14

    Sep

  • 15

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 05

    Oct

  • 13

    Nov

CTSH Cognizant
$71.42

0.49 (0.69%)

08/08/17
BREN
08/08/17
UPGRADE
Target $85
BREN
Buy
Cognizant upgraded to Buy on less immigration risk at Berenberg
Berenberg analyst Georgios Kertsos upgraded Cognizant Technology Solutions to Buy from Hold and raised his price target for the shares to $85 from $65. The market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors, Kertsos tells investors in a research note. The analyst also thinks upside from potential U.S. tax reforms are not priced into Cognizant shares.
08/04/17
FBCO
08/04/17
NO CHANGE
Target $80
FBCO
Outperform
Cognizant price target raised to $80 from $70 at Credit Suisse
After its Q2 report, Credit Suisse analyst Charles Brennan said Cognizant (CTSH) remains one of the fastest growing companies in Computer Services & IT Consulting and deserves a valuation more in line with slower-growing peer Accenture (ACN). The analyst raised his price target on Cognizant to $80 from $70 and keeps an Outperform rating on the shares.
08/08/17
BREN
08/08/17
UPGRADE
Target $85
BREN
Buy
Cognizant upgraded to Buy from Hold at Berenberg
08/08/17
08/08/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Argus with analyst William Selesky saying he expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in fiscal 2019. 2. L3 Technologies (LLL) upgraded to Buy from Hold at Drexel Hamilton analyst Pete Skibitski saying he is "cautiously" optimistic that there will be a positive resolution in fiscal 2018 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed. 3. Foot Locker (FL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jay Sole saying he believes share weakness related to investor concerns surrounding share loss to Amazon (AMZN) and brands' own websites has created an "excellent" buying opportunity. 4. UPS (UPS) upgraded to Buy from Neutral at Citi with analyst Christian Wetherbee saying he sees a "clear path" toward double-digit earnings growth returning in 2018. 5. Cognizant (CTSH) upgraded to Buy from Hold at Berenberg with analyst Georgios Kertsos saying the market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MX MagnaChip
$11.45

-0.35 (-2.97%)

05/03/17
05/03/17
NO CHANGE

MagnaChip reports Q1 adjusted EPS 1c, consensus (9c)
Reports Q1 revenue $161.7M, consensus $160M.
05/10/17
05/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. FactSet (FDS) initiated with a Hold at Deutsche Bank. 2. Cadence Bancorporation (CADE) was initiated with an Overweight at Stephens and an Outperform at Baird. 3. MagnaChip (MX) initiated with a Neutral at Citi. 4. Semtech (SMTC) initiated with an Outperform at Baird. 5. Lion Biotechnologies (LBIO) initiated with a Buy at Rodman & Renshaw. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/13/17
NEED
01/13/17
UPGRADE
NEED
Buy
MagnaChip upgraded to Buy from Hold at Needham
05/10/17
SBSH
05/10/17
INITIATION
Target $10.5
SBSH
Neutral
MagnaChip initiated with a Neutral at Citi
Citi analyst Atif Malik started MagnaChip with a Neutral rating and $10.50 price target. The analyst views the shares as fairly valued.
SLAB Silicon Laboratories
$74.65

-1.3 (-1.71%)

02/02/17
ADAM
02/02/17
NO CHANGE
Target $80
ADAM
Buy
Silicon Laboratories price target raised to $80 from $71 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Silicon Labs to $80 from $71 following strong Q4 results. The analyst believes margins guidance could be raised at the company's March analyst day meeting. He sees the company as a compelling growth story with accelerating sales and earnings growth and a valuable consolidation candidate with a leading IoT business and operating expense leverage. Ramsay reiterated his Buy rating on Silicon Labs.
03/07/17
ROTH
03/07/17
NO CHANGE
Target $80
ROTH
Buy
Silicon Laboratories price target raised to $80 from $75 at Roth Capital
Roth Capital analyst Suji Desilva raised his price target for Silicon Laboratories to $80 from $75 as he expects shares to continue to improve with revenue growth and sustained healthy margins. The analyst believes Silicon Laboratories represents a differentiated investment opportunity in embedded controller, connectivity and sensor content for the growing Internet of Things market. He reiterates a Buy rating on the shares.
04/27/17
ROTH
04/27/17
NO CHANGE
Target $85
ROTH
Buy
Silicon Laboratories price target raised to $85 from $80 at Roth Capital
Roth Capital analyst Suji Desilva raised his price target for Silicon Laboratories to $85 from $80 as he is encouraged that the company is growing Internet of Things and infrastructure revenues and increasing its contribution in the mix. The analyst also expects shares to continue to improve with growth across Internet of Things and infrastructure. He reiterates a Buy rating on the shares.
06/07/17
BNCH
06/07/17
NO CHANGE
Target $10
BNCH
Buy
Sigma Designs could become 'prime acquisition target,' says Benchmark
Following Sigma Designs' (SIGM) report of mixed Q1 results, Benchmark analyst Gary Mobley contends investors care about two main things: growing IoT revenue, which is being seen, and an "outright divestiture" of SmartTV assets. If Sigma can shed assets and become a pure play IoT chip/cloud infrastructure company, Mobley believes it could become a "prime acquisition target" for a radio frequency IC company such as Silicon Laboratories (SLAB) or MaxLinear (MXL). If it is not acquired but can raise $100M by selling non-core, non-IoT businesses, Sigma could make additional acquisitions to bolster its IoT focus, said Mobley, who keeps a Buy rating and $10 price target on the stock.
XRX Xerox
$31.88

-0.27 (-0.84%)

08/02/17
SBSH
08/02/17
NO CHANGE
Target $39
SBSH
Buy
Citi sees 'big positive turn' at Xerox, ups target to $39
Xerox is a "making a big positive turn" as it remains on track for its cost saving and operating margin improvements while its new leadership team is "starting to regain investor credibility," Citi analyst Jim Suva tells investors in a research note. The analyst expects revenue declines to moderate in the second half of 2017 with new products launching mid-year. He views the valuation as attractive and upped his price target for the shares to $39 from $36. Suva reiterates a Buy rating on Xerox.
07/24/17
07/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Huntsman (HUN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Michael Sison saying he believes HuntsmanClariant will generate "attractive earnings growth" through the end of the decade. He also sees the IPO of Venator (VNTR) as a potential catalyst. 2. Caterpillar (CAT) upgraded to Outperform from Market Perform at BMO Capital with analyst Joel Tiss saying he expects the company to provide five year Earnings Per Share guidance at its September investor event "that could approach" his $16 outlook. 3. Michaels (MIK) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Horvers saying the risk/reward at current share levels is attractive. 4. Xerox (XRX) upgraded to Equal Weight from Underweight at Barclays with analyst Mark Moskowitz saying better market conditions and cost take-outs could help the company improve revenue and margins. 5. Leggett & Platt (LEG) upgraded to Long-Term Buy from Neutral at Hilliard Lyons with analyst Spencer Joyce saying the upgrade is not a call on Q2 results, but does expect positive commentary toward second half 2017 and believes valuation provides a compelling long-term entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/17
LOOP
07/24/17
INITIATION
Target $36
LOOP
Buy
Xerox initiated with a Buy at Loop Capital
Loop Capital analyst Ananda Baruah initiated Xerox with a Buy and a $36 price target saying the more focused company following the split from its services business will create greater benefits for a company that has a solid history of strong cash flow and believes normalized earnings may reach $4 in 2019.
07/24/17
LEHM
07/24/17
UPGRADE
Target $33
LEHM
Equal Weight
Xerox upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Mark Moskowitz upgraded Xerox to Equal Weight and raised his price target for the shares to $33 from $27. Better market conditions and cost take-outs could help the company improve revenue and margins, Moskowitz tells investors in a research note. The analyst expect the stock's valuation to rerate higher as consensus estimates move up.
WIX Wix.com
$66.15

1 (1.53%)

08/15/17
RHCO
08/15/17
INITIATION
Target $73
RHCO
Buy
Wix.com initiated with a Buy at SunTrust
SunTrust analyst Youssef Squali started Wix.com with a Buy rating and $73 price target.
08/16/17
08/16/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), GoDaddy (GDDY), Wix.com (WIX), Alibaba (BABA), Amazon.com (AMZN), and Priceline (PCLN) were initiated with a Buy at SunTrust, while Snap (SNAP) was initiated with a Sell, and Twitter (TWTR) and eBay (EBAY) were initiated with a Hold. 2. HD Supply (HDS) reinstated with a Neutral at Goldman Sachs. 3. Shiloh Industries (SHLO) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/17
JEFF
08/24/17
INITIATION
JEFF
Buy
Wix.com initiated with a Buy at Jefferies
Jefferies analyst Brent Thill initiated Wix.com with a Buy and a $74 price target.
07/28/17
NEED
07/28/17
NO CHANGE
Target $86
NEED
Strong Buy
Wix.com selloff a buying opportunity, says Needham
Needham analyst Kerry Rice views the post-earnings weakness in shares of Wix.com as a buying opportunity. With its recent history of beat and raise quarters, a beat and maintain guidance print "comes as a disappointment to some," Rice tells investors in a research note. The analyst continues to expect "strong" revenue and collections growth of 46% and 39%, respectively, as well as FY17 free cash flow to nearly double. The analyst keeps a Buy rating on Wix.com with an $86 price target.
QRVO Qorvo
$73.22

-0.1 (-0.14%)

08/02/17
OPCO
08/02/17
NO CHANGE
OPCO
Supply chain to react positively following Apple results, says Oppenheimer
Oppenheimer analyst Rick Schafer expects the Apple (AAPL) supply chain to react positively, as Apple's guidance likely implies limited impact from any possible launch/production delays. Within the company's supply chain, the analyst continues to prefer content increase stories helping insulate from any demand softness versus expectations. His top picks in the Apple supply chain are content-driven growth stories Broadcom (AVGO) and Skyworks (SWKS). Schafer remains on the sidelines on Cirrus Logic (CRUS) and Qorvo (QRVO) heading into their respective prints tomorrow.
09/05/17
NOMU
09/05/17
INITIATION
Target $75
NOMU
Neutral
Qorvo initiated with a Neutral at Nomura Instinet
Krysten Sciacca initiated Qorvo with a Neutral and a $75 price target due to recent execution issues.
09/06/17
NOMU
09/06/17
INITIATION
Target $75
NOMU
Neutral
Qorvo initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Krysten Sciacca started Qorvo with a Neutral rating and $75 price target. The analyst says the company's "mixed" track record on execution keeps her on the sidelines.
06/16/17
JPMS
06/16/17
NO CHANGE
Target $85
JPMS
Overweight
Qorvo should be bought at current levels, says JPMorgan
After hosting investor meetings with management, JPMorgan analyst Bill Peterson recommends using the recent pullback in shares of Qorvo as a buying opportunity. The company's non-mobile business, representing 21% of revenue and growing at 23%, is "particularly underappreciated," Peterson tells investors in a research note. He expects Qorvo to deliver "at least" high-single revenue growth and gross margin expansion with "significant" operating leverage over the next few years. The analyst keeps an Overweight rating on the shares with an $85 price target.
TRVG trivago
$11.51

-0.98 (-7.85%)

08/07/17
JPMS
08/07/17
NO CHANGE
Target $23
JPMS
Overweight
trivago earnings selloff a buying opportunity, says JPMorgan
JPMorgan analyst Doug Anmuth recommends using Friday's 19% post-earnings selloff in shares of trivago as a buying opportunity. The analyst sees no structural changes to trivago's platform and views the share pullback as overdone. He reiterates an Overweight rating on the name with a $23 price target.
09/07/17
09/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. trivago (TRVG) downgraded to Neutral from Buy at BofA/Merrill with analyst Nat Schindler citing a surprise lowering of its 2017 revenue growth target to 40% from 50% and reduced adjusted EBITDA to down year-over-year. 2. Carrizo Oil & Gas (CRZO) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan saying Carrizo faces too many near-term headwinds and doesn't see Net Asset Value upside driving near-term stock outperformance. 3. Varian Medical (VAR) downgraded on valuation, macro concerns at BTIG with analyst Sean LAvin saying he downgraded the stock "mainly on valuation." However, he also believes that the company's results could be hurt by "instability in Korea and multiple hurricanes." 4. Zymeworks (ZYME) assumed with an Underweight from Overweight at Barclays with analyst Gena Wang saying she has low expectations for the company's lead asset HER2 dispecific antibody ZW25 in HER and high and medium expressed breast cancer. 5. Sealed Air (SEE) downgraded to Neutral from Buy at Citi with analyst Anthony Pettinari saying the company's annual guidance is at risk due to resin headwinds post Hurricane Harvey. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/17
JPMS
09/07/17
NO CHANGE
Target $16
JPMS
Overweight
trivago price target lowered to $16 from $23 at JPMorgan
JPMorgan analyst Doug Anmuth lowered his price target for trivago shares to $16 from $23 and his earnings estimates "significantly" citing the company's softer 2017 outlook. The analyst admits the stock could be range-bound, but he keeps an Overweight rating on the name, saying the company's "scaled, high quality platform" remains a valuable source of customers for Priceline (PCLN), Expedia (EXPE) and others.
09/07/17
BOFA
09/07/17
DOWNGRADE
Target $14
BOFA
Neutral
trivago downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Nat Schindler downgraded trivago to Neutral and slashed his price target on shares to $14 from $22 following a surprise lowering of its 2017 revenue growth target to 40% from 50% and reduced adjusted EBITDA to down year-over-year. The analyst said the primary driver for the revenue deceleration in premium payments as advertisers improved their sites, reducing bid premiums. Schindler said the challenges seem specific to trivago and remains positive on online travel agencies.
MKSI MKS Instruments
$84.90

1.65 (1.98%)

07/05/17
DBAB
07/05/17
INITIATION
Target $84
DBAB
Buy
MKS Instruments initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Sidney Ho started MKS Instruments with a Buy rating and $84 price target. The analyst views the recent pullback in shares as a buying opportunity and believes the Street is underestimating the company's ability to drive margin expansion and deleverage its balance sheet.
01/24/17
DOTC
01/24/17
UPGRADE
DOTC
Buy
MKS Instruments upgraded to Buy from Neutral at Dougherty
10/12/16
PACS
10/12/16
NO CHANGE
Target $59
PACS
Overweight
MKS Instruments price target raised to $59 from $51 at Pacific Crest
Pacific Crest analyst Weston Twigg raised his price target for MKS Instruments (MKSI) to $59 saying the acquisition of Newport offers earnings leverage and growth potential beyond semiconductors. The company should grow faster than most semiconductor equipment companies if the semiconductor side slows down, Twigg tells investors in a research note. He sees "a lot to like here" and keeps an Overweight rating on the shares. Citi this morning initiated MKS with a Buy rating.
07/10/17
SBSH
07/10/17
NO CHANGE
Target $92
SBSH
Buy
MKS Instruments added to SMID Focus List at Citi
Citi analyst Scott Chronert added MKS Instruments to his firm's SMID Focus List following the recent 20% pullback in the shares. The upcoming Semicon West show and Q2 earnings results should reinforce the growth thesis, Chronert tells investors in a research note. He has a Buy rating on the shares with a $92 price target.
TEL TE Connectivity
$78.80

-0.35 (-0.44%)

01/04/17
GSCO
01/04/17
DOWNGRADE
Target $64
GSCO
Sell
TE Connectivity downgraded to Sell from Neutral at Goldman
Goldman Sachs analyst Mark Delaney downgraded TE Connectivity to Sell citing the stock's outperformance in 2017 and his firm's expectations for auto production to decelerate starting in 2017. The analyst raised his price target for the shares to $64 from $63.
01/12/17
LBOW
01/12/17
UPGRADE
LBOW
Buy
TE Connectivity upgraded to Buy from Neutral at Longbow
01/12/17
LBOW
01/12/17
UPGRADE
LBOW
Buy
TE Connectivity upgraded on imrpoving industrial demand at Longbow
As noted earlier, Longbow upgraded TE Connectivity to Buy from Neutral. Analyst Shawn Harrison says his checks indicate that the company's North American industrial market sales beat expectations in Q4. He adds that the company's book to bill ratio appears to have hit its highest level since the end of 2013.
03/21/17
COWN
03/21/17
INITIATION
Target $90
COWN
Outperform
TE Connectivity initiated with an Outperform at Cowen
Cowen analyst Joseph Giordano initiated TE Connectivity with an Outperform and a $90 price target.
TXN Texas Instruments
$82.00

-0.07 (-0.09%)

06/16/17
06/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hasbro (HAS) initiated with a Buy at Argus. 2. Kindred Biosciences (KIN) initiated with a Buy at Aegis. 3. Stanley Black & Decker (SWK) was initiated with a Buy at Seaport Global and resumed with an Outperform at Raymond James. 4. McCormick (MKC) initiated with a Neutral at Goldman Sachs. 5. Texas Instruments (TXN) resumed with a Market Perform at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/17
JPMS
07/10/17
NO CHANGE
JPMS
JPMorgan raises semiconductor market forecasts after strong May
JPMorgan analyst Hisashi Moriyama attributes data center demand due to the spread of cloud computing and expanding applications for Internet of Things as driving better than expected May growth in the semiconductor market. The analyst, who also believes growth to the automobile market is accelerating, raised his semiconductor market forecasts given the strong May. Publicly traded companies in the semiconductor space include AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Micron (MU), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN).
07/26/17
SBSH
07/26/17
NO CHANGE
Target $97
SBSH
Buy
Texas Instruments price target raised to $97 from $87 at Citi
Citi analyst Christopher Danely raised his price target for Texas Instruments to $97 saying the company reported strong Q2 results and guided above expectations "due to broad-based strength." He believes Texas Instruments has one of the highest total returns in Citi's coverage universe. The analyst keeps a Buy rating on the shares.
07/24/17
RBCM
07/24/17
NO CHANGE
RBCM
Texas Instruments June results poised to beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani, predicts that Texas Instruments' June quarter results will beat expectations, while its September quarter guidance range will include the consensus outlook. The analyst says that the company's "revenue backdrop" was "favorable" last quarter, and he thinks that Analog demand continues to be "robust." He keeps a $95 price target and an Outperform rating on the stock.
FEYE FireEye
$15.77

0.99 (6.70%)

09/07/17
MSCO
09/07/17
UPGRADE
MSCO
Overweight
FireEye upgraded to Overweight from Equal Weight at Morgan Stanley
09/07/17
09/07/17
UPGRADE
Target $19

Overweight
FireEye upgraded to Overweight on Helix potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Melissa Franchi upgraded FireEye to Overweight from Equal Weight, stating that the firm's customer survey suggests the adoption potential for the company's new Helix solution is significantly higher than consensus assumes. Also, while investors are pricing in continued declines in the FireEye subscription base, she thinks stabilization in recent results and positive spending indications from customers surveyed point to that not being the case, Franchi tells investors. She raised her price target on FireEye shares to $19 from $13.
06/20/17
EVER
06/20/17
NO CHANGE
EVER
CyberArk, Imperva added to Small'Medium Ideas List at Evercore ISI
Evercore ISI analyst Ken Talanian added CyberArk (CYBR) and Imperva (IMPV) to the firm's Small/Medium Core Ideas List and dropped FireEye (FEYE) and Proofpoint (PFPT) from the list. The analyst says that CyberArk and Imperva are better positioned to benefit from the EU's General Data Protection Regulation, or GDPR, which seeks to strengthen the bloc's data security capabilities by forcing companies to meet certain standards by May 2018. The analyst says that CyberArk is well-positioned to be boosted by GDPR because of its focus on insider threats, while Imperva's focus on data security makes it "especially likely to benefit" from GDPR, according to the analyst.
08/22/17
GSCO
08/22/17
NO CHANGE
GSCO
FireEye product customer reviews have been good, says Goldman Sachs
Goldman analyst Gabriela Borges said customer reviews on FireEye's endpoint product have been good, and believes the company is being very strategic with its pricing and go-to-market efforts in the second half. Borges rates FireEye a Buy.
MXIM Maxim Integrated
$46.36

-0.2 (-0.43%)

08/31/17
LOOP
08/31/17
NO CHANGE
Target $53
LOOP
Buy
Loop recommends adding to Maxim Integrated positions ahead of update meeting
Loop Capital analyst Betsy Van Hees said her recent meeting with Maxim Integrated's investor relations team gave her the sense the company was likely being conservative with its previously issued Q1 outlook and she predicts it will narrow its outlook to the higher-end of the guidance ranges when it holds its business model update call next week. She believes Street estimates for Maxim are poised to likely go higher and recommends adding to positions ahead of the update meeting. Van Hees keeps a Buy rating and $53 price target on Maxim Integrated shares.
07/21/17
DBAB
07/21/17
NO CHANGE
Target $50
DBAB
Buy
Maxim Integrated weakness a buying opportunity, says Deutsche Bank
Deutsche Bank analyst Ross Seymore views near-term weakness in shares of Maxim Integrated following the company's Q4 results as a buying opportunity. Weaker than expected sales in Q4 and guidance "will overwhelm" any positive takes on the company's "impressive" margins, Seymore tells investors in a research note. The analyst likes the stock's risk/reward and keeps a Buy rating on the name with a $50 price target.
06/15/17
RAJA
06/15/17
INITIATION
RAJA
Market Perform
Maxim Integrated resumed with a Market Perform at Raymond James
Raymond James analyst Chris Caso resumed coverage on Maxim with a Market Perform citing valuation.
04/21/17
EVER
04/21/17
DOWNGRADE
Target $46
EVER
In Line
Maxim Integrated downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst C.J. Muse downgraded Maxim Integrated saying the diversification/margin story is largely complete and shares are near his $46 price target. Muse sees modest headwinds ahead including slowing China BMS business and lack of Apple exposure in 2H and recommends moving to the sidelines.
TYL Tyler Technologies
$169.87

-0.23 (-0.14%)

02/09/17
PACS
02/09/17
NO CHANGE
PACS
Tyler Technologies should be bought on weakness, says Pacific Crest
After Tyler reported higher than expected EPs but lower than expected revenue, Pacific Crest analyst Brent Bracelin says that the company's revenue could increase 12% this year versus his previous estimate of 11%. The analyst says that the company's "disappointing" EPS guidance is partly due to increased R&d investments. Bracelin calls the company "a high-quality franchise that has a dominant position in local government with few competitive risks." He recommends buying the stock on weakness.
10/28/16
PACS
10/28/16
NO CHANGE
PACS
Tyler Technologies should be bought on weakness, says Pacific Crest
After Tyler reported lower than expected revenue and the stock fell sharply, Pacific Crest analyst Brent Bracelin says that the company's backlog remains strong, and its fundamentals are "healthy." He adds that its EBITDA growth could still exceed 25%, while the compsny has a $13B TAM. He recommends buying the shares on weakness.
07/18/17
MAXM
07/18/17
NO CHANGE
Target $197
MAXM
Buy
Tyler win in Vermont highlights competitive edge, says Maxim
Maxim analyst Brian Kinstlinger noted that Vermont announced on June 30 that it has selected Tyler Technologies' Odyssey case management system to implement statewide and he believes the company is also positioned for CMS procurement awards in Kansas and South Australia. The analyst, who highlighted the Vermont win as further evidence of Tyler's competitive edge in CMS procurements, keeps a Buy rating and $197 price target on the stock.
07/27/17
BNCH
07/27/17
NO CHANGE
Target $190
BNCH
Buy
Tyler Technologies weakness a good opportunity to buy, says Benchmark
Benchmark analyst Mark Schappel said he believes Tyler Technologies' story is intact despite the company's "middling" 2Q results and he views post-earnings weakness as a good opportunity to buy shares and what he expects to be a "short-lived" discount. He keeps a Buy rating and $190 price target on Tyler shares.
AMKR Amkor Technology
$8.90

-0.03 (-0.34%)

PFPT Proofpoint
$91.66

0.92 (1.01%)

06/28/17
PIPR
06/28/17
NO CHANGE
PIPR
Piper highlights Proofpoint, Symantec after global ransomware attack
Piper Jaffray analyst Andrew Nowinski says he continues to recommend Proofpoint (PFPT) and Symantec (SYMC) as top security picks following yesterday's global ransomware attack. Both companies trade at a "substantial discount" to the peer group and are well positioned to capitalize on the increasing breach activity, the analyst contends.
07/14/17
WEDB
07/14/17
NO CHANGE
WEDB
Proofpoint checks positive, says Wedbush
Wedbush analyst Steve Koenig says his firm's checks indicate that Proofpoint "is continuing to beat the competition and generate robust growth." The analyst expects the company's Q2 results to beat expectations and recommends buying shares ahead of the results.
08/17/17
COWN
08/17/17
INITIATION
Target $105
COWN
Outperform
Proofpoint initiated with an Outperform at Cowen
Cowen analyst Gregg Moskowitz initiated Proofpoint with an Outperform rating as he believes the company is poised to capitalize on customers increasingly transitioning to the cloud. The analyst also cited an improved product portfolio and confidence the company will gain significant market share in bot its protection and archiving segments. Moskowitz has a $105 price target on Proofpoint shares.
07/28/17
PIPR
07/28/17
NO CHANGE
Target $100
PIPR
Overweight
Proofpoint price target raised to $100 from $90 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for Proofpoint to $100 saying the company reported "another predictable quarter, with all metrics exceeding consensus and the high-end of guidance." The analyst views the Q3 guidance as conservative and keeps an Overweight rating on Proofpoint shares.
GWRE Guidewire
$80.06

6.83 (9.33%)

09/05/17
KEYB
09/05/17
NO CHANGE
Target $75
KEYB
Overweight
KeyBanc would be a buyer of Guidewire on a pullback
KeyBanc analyst Monika Garg notes that Guidewire is expected to report results this week, and she expects a slight beat and the company to issue in-line to modestly higher FY18 guidance. Garg would be a buyer on a pullback. She reiterates an Overweight rating and $75 price target on the shares.
06/13/17
06/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Berenberg with analyst Alexander Haissl arguing that the threat of traditional car manufactures to Tesla is overstated. Traditional carmakers are yet to demonstrate a clear pathway to mass-market electric vehicles that can realistically compete with Tesla, Haissl tells investors in a research note. He calls the near-term for Tesla "unimportant" and views company's margin and free cash flow potential over the long-term as "superior." 2. Tableau (DATA) upgraded to Buy from Neutral at Goldman Sachs with analyst Jesse Hulsing saying the company's transition to predominantly recurring revenue can drive nearly $1.2B of annual recurring revenue by the second quarter of 2020. 3. Sherwin-Williams (SHW) upgraded to Buy from Neutral at Longbow with analyst Dmitry Silverstein citing improving same-store volume trends, a growing DIY channel, Valspar integration and accretion, and possible margin upside form price increases and/or a reversal in raw material prices. 4. Regional Management (RM) upgraded to Outperform from Market Perform at JMP Securities with analyst David Scharf saying the company's delinquencies have reached the lowest level since it went public in 2012, and he thinks that changes it is making will enhance its credit management capabilities. 5. Guidewire (GWRE) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alex Zukin saying the recent quarter suggests accelerating revenue growth and improving profitability. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/28/17
PIPR
08/28/17
NO CHANGE
Target $80
PIPR
Overweight
Piper ups Guidewire target to $80, says buy into quarter
Piper Jaffray analyst Alex Zukin recommends buying shares of Guidewire Software into the company's Q4 results on September 6. Channel checks suggest Guidewire closed out the year with a "very strong quarter by successfully executing on a number of large deals," Zukin tells investors in a pre-earnings research note. He raised his price target for the shares to $80 from $75 and reiterates an Overweight rating on Guidewire.
09/07/17
JMPS
09/07/17
NO CHANGE
JMPS
Market Perform
Guidewire cloud momentum accelerating, says JMP Securities
JMP Securities analyst Rishi Jaluria noted that Guidewire Software shares were down fractionally in afterhours trading following the company's Q4 report, attributable partially to lower than expected Q1 guidance and to commentary that gross margins could be pressured in FY18. However, the analyst points out that Guidewire's cloud momentum is accelerating and said higher subscription adoption and investments will benefit it in the long term. Jaluria keeps a Market Perform rating on Guidewire shares, citing valuation.
BL BlackLine
$32.18

1.31 (4.24%)

06/26/17
JMPS
06/26/17
INITIATION
JMPS
Market Perform
BlackLine initiated with a Market Perform at JMP Securities
JMP Securities analyst Patrick Walravens started coverage of BlackLine with a Market Perform rating. He says that shares are "fairly valued" at current levels, but he recommends that investors look for a better entry point, as he believes that its "value proposition" is "compelling."
02/28/17
BARD
02/28/17
INITIATION
Target $33
BARD
Outperform
BlackLine assumed with an Outperform at Baird
Baird analyst Rob Oliver assumed coverage on BlackLine with an Outperform and $33 price target.
06/26/17
RHCO
06/26/17
INITIATION
Target $43
RHCO
Buy
BlackLine initiated with a Buy at SunTrust
SunTrust analyst Terry Tillman initiated BlackLine with a Buy and a $43 price target saying it is a 30% topline grower and its recently launched Intercompany hub is a catalyst for a new product cycle and strategic partnerships. The analyst is confident in potential upside to revenue estimates and thinks positive free cash flow by Q4 could act as a catalyst.
04/18/17
BARD
04/18/17
NO CHANGE
Target $35
BARD
Outperform
BlackLine remains a favorite secular growth story, says Baird
Baird analyst Rob Oliver said BlackLine remains a favorite small/midcap secular growth story that can deliver upside to forecasts. Oliver, who sees strong momentum and a robust pipeline, reiterated his Outperform rating and raised his price target to $35 from $33 on BlackLine shares.
IIVI II-VI
$36.50

0.05 (0.14%)

08/08/17
BNCH
08/08/17
NO CHANGE
Target $44
BNCH
Buy
II-VI price target raised to $44 from $40 at Benchmark
Benchmark analyst Mark Miller noted II-VI beat expectations for earnings and revenue and he sees double digit growth opportunities for the company in several areas. He keeps a Buy rating on II-VI shares and raised his price target on the stock to $44 from $40.
04/06/17
BNCH
04/06/17
NO CHANGE
BNCH
Buy
II-VI recent weakness on VCSEL concerns a buying opportunity, says Benchmark
Benchmark analyst Mark Miller attributes recent weakness in shares of II-VI (IIVI) to reports on delays related to the introduction of VCSEL-based sensors for 3D imaging in Apple's (AAPL) iPhone 8 and concerns about VCSEL yield issues. Some investors think VCSELs represent a significant revenue opportunity in 2017 for II-VI, but Miller points out that II-VI management recently emphasized that its U.S. VCSEL ramp will primarily come in 2018. He actually views the reports as good news for II-VI, and potentially bad news for assumed first movers Lumentum (LITE) and Finisar (FNSR), he tells investors. Miller keeps a Buy rating on II-VI and sees the weakness as a buying opportunity.
07/26/17
RILY
07/26/17
DOWNGRADE
Target $35.75
RILY
Neutral
II-VI downgraded to Neutral from Buy at B. Riley
B. Riley analyst Dave Kang downgraded II-VI to Neutral saying Chinese optical demand remains soft while 3D sensing revenue "could be underwhelming." The analyst lowered his price target for the shares to $35.75 from $39.50.
07/24/17
CHLM
07/24/17
INITIATION
Target $50
CHLM
Buy
II-VI initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon started II-VI with a Buy rating, predicting that its optical assets acquired with the deal for Oclaro and the emergence of the 3D sensing market can accelerate its growth to 20% from about 5%. The analyst, who forecasts nearly $3 of EPS in FY19, but sees an upside case to $4.50, set a $50 price target on II-IVI shares.
BRKS Brooks Automation
$27.23

1.44 (5.58%)

08/07/17
STFL
08/07/17
UPGRADE
STFL
Buy
Brooks Automation upgraded on valuation, life sciences outlook at Stifel
As noted earlier, Stifel upgraded Brooks to Buy from Hold. Analyst Patrick Ho upgraded the stock based on valuation and his more upbeat view of the company's life sciences business which he says is "on track for strong growth in 2018." Target to $32 from $22.
07/06/17
NEED
07/06/17
NO CHANGE
Target $28
NEED
Buy
Needham sees Brooks Automation selloff as buying opportunity
Needham analyst Y. Edwin Mok notes that Brooks Automation announced the acquisition of Pacific Bio-Material Management, which he believes is a similar deal to the very successful BioStorage acquisition, further pushing the company into a service-based recurring business that should enhance the consistent growth trajectory of the life science business. The analyst sees the recent sell-off as buying opportunity given solid fundamentals, and reiterates a Buy rating and $28 price target on the shares.
08/06/17
STFL
08/06/17
UPGRADE
STFL
Buy
Brooks Automation upgraded to Buy from Hold at Stifel
05/01/17
FBCO
05/01/17
NO CHANGE
Target $25.5
FBCO
Neutral
Brooks Automation price target raised to $25.50 from $19 at Credit Suisse
Credit Suisse analyst Farhan Ahmad raised his price target for Brooks Automation to $25.50 from $19 after the company reported Q2, and guided Q3 above estimates. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.